As of Mar 23
| -0.0101 / -2.93%|
The 4 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 4.00 and a low estimate of 2.00. The median estimate represents a +497.19% increase from the last price of 0.33.
The current consensus among 4 polled investment analysts is to Hold stock in Anthera Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.